Thought Leadership Insights

Join our CEO, Cerlin Roberts, as she sits down with leading industry voices to explore the ideas, innovations, and themes shaping their work.

Shaping the Future of Discovery & Development

In the lead-up to this year’s event a selection of featured speakers explore the ideas shaping the future of our industry. These conversations offer a preview of the insights, innovations, and strategic thinking that will define this year’s programme and an indication of what you will be able to hear from them, first hand, at the event.

We will continue to add to these over the coming weeks, so check back for more!

Thought Leadership Top Section Image-1

Josh Bagley

Chief Scientific Officer,
a:head bio AG

Don't Miss Josh's Sessions at Drug Discovery Europe 2026

Robin Roehm

Chief Executive Officer,
Apheris AI GmbH

Don't Miss Robin's Sessions at Drug Discovery Europe 2026



Paul Workman

Harrap Professor of Pharmacology and Therapeutics,
The Institute of Cancer Research, London

Joshua Bagley

Chief Scientific Officer,
a:head bio AG

Steinunn Sara Helgudottir

Chief Scientific Officer,
Neurometa Therapeutics

Rafal Kaminski

Chief Scientific Officer,
Angelini Pharma

Yann Gaston-Mathe

Chief Executive Officer,
Iktos AI

Robin Roehm

Chief Executive Officer,
Apheris AI GmbH

Mahendra Deonarain

Chief Executive Officer,
Antikor Biopharma Ltd


Drug Discovery Laptop Screen Mockup

Discover Your Unmissable Schedule

Discover everything our event has to offer by exploring the agenda page. There, you’ll find detailed information on every presentation, from inspiring keynote addresses to engaging panel discussions. You can also personalise your experience by saving your favourite sessions and building a tailored agenda that fits your interests and schedule, so you never miss the moments that matter most.

Berlin. 15-16 June.

Over 1,000 senior scientists and R&D leaders are already registered across Drug Discovery Europe, Formulation and Delivery Europe and Automation, AI and Data Europe.

The exhibition is close to capacity. The conversation is worth having now.